Zobrazeno 1 - 10
of 107
pro vyhledávání: '"Yusuke Miwa"'
Publikováno v:
Acute Medicine & Surgery, Vol 10, Iss 1, Pp n/a-n/a (2023)
Externí odkaz:
https://doaj.org/article/64a11f2362c44a5d95afddd359a5762a
Autor:
Yusuke Miwa, Yuko Mitamura
Publikováno v:
European Journal of Rheumatology, Vol 7, Iss 2, Pp 60-63 (2020)
Externí odkaz:
https://doaj.org/article/e7f2814ab32847e8a460bb0e1223527c
Autor:
Saito Mayu, Sakiko Isojima, Yoko Miura, Shinichiro Nishimi, Mika Hatano, Takahiro Tokunaga, Ryo Takahashi, Keiko Koide, Yusuke Miwa
Publikováno v:
Case Reports in Rheumatology, Vol 2019 (2019)
Polymyositis-dermatomyositis is extremely rare during pregnancy, and immunosuppressive therapy should be administered after carefully considering the effects on both the mother and fetus. Several reports have associated the disease activity with feta
Externí odkaz:
https://doaj.org/article/48999db9c17f4c9a975a40fff7feb375
Autor:
Takeo Isozaki, Nobuyuki Yajima, Michihito Sato, Ryo Takahashi, Kuninobu Wakabayashi, Yusuke Miwa, Masao Negishi, Hirotsugu Ide, Tsuyoshi Kasama
Publikováno v:
Clinical Medicine Insights: Case Reports, Vol 2010, Iss 3, Pp 63-68 (2010)
Externí odkaz:
https://doaj.org/article/f3f59a00b45d47e49605feb18b8bed82
Publikováno v:
Catalysis Science & Technology. 13:1725-1734
Catalytic CH4 oxidation activity of a μ-nitrido-bridged heterodimer of an iron phthalocyanine and an iron porphycene in an aqueous solution containing excess H2O2 was examined.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc91a35f27df21bb3a04b50584fad153
https://doi.org/10.1039/d2cy01980a
https://doi.org/10.1039/d2cy01980a
Autor:
Kohei Maeda, Toshihiro Tanioka, Rei Takahashi, Hideaki Watanabe, Hirohiko Sueki, Masafumi Takimoto, Shin-ichi Hashimoto, Kazuho Ikeo, Yusuke Miwa, Tsuyoshi Kasama, Sanju Iwamoto
Publikováno v:
The Journal of Immunology.
Recent studies have highlighted the pathogenic roles of IL-17–producing CD8+ T cells (T-cytotoxic 17 [Tc17]) in psoriasis. However, the underlying mechanisms of Tc17 induction remain unclear. In this study, we focused on the pathogenic subsets of T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5233aacf141435cd31ca9d70d01a5647
https://doi.org/10.4049/jimmunol.2200530
https://doi.org/10.4049/jimmunol.2200530
Autor:
Naoki Kimura, Takuya Kawahara, Yukari Uemura, Tatsuya Atsumi, Takayuki Sumida, Toshihde Mimura, Yasushi Kawaguchi, Hirofumi Amano, Yukiko Iwasaki, Yuko Kaneko, Toshihiro Matsui, Yoshinao Muro, Yoshitaka Imura, Takashi Kanda, Yoshiya Tanaka, Atsushi Kawakami, Masatoshi Jinnin, Tomonori Ishii, Keiju Hiromura, Yusuke Miwa, Hiroshi Nakajima, Masataka Kuwana, Yasuhiko Nishioka, Akio Morinobu, Hideto Kameda, Hitoshi Kohsaka
Publikováno v:
Rheumatology. 61:4445-4454
Objectives To assess the efficacy and safety of branched chain amino acids (BCAAs) in the treatment of PM/DM prior to official approval of their use in Japan. Methods Treatment naïve adults with PM/DM were enrolled in a randomized, double-blind tria
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93d0ee6ff46780a188dd8c75e98af8ae
https://doi.org/10.1093/rheumatology/keac101
https://doi.org/10.1093/rheumatology/keac101
Autor:
Kosuke Sakurai, Noriko Kohyama, Takahiro Okada, Yusuke Miwa, Miki Takenaka, Mari Kogo, Takashi Yamaguchi, Tatsuya Kurihara
Publikováno v:
Internal Medicine
Objective We aimed to develop a scoring model to predict a low disease activity (LDA) in elderly rheumatoid arthritis (RA) patients initially treated with biological disease-modifying antirheumatic drugs (bDMARDs). Methods This retrospective cohort s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9af465b461498849a6e87cac026227d5
https://doi.org/10.2169/internalmedicine.6251-20
https://doi.org/10.2169/internalmedicine.6251-20
Autor:
Kei Ito, Masataka Yoshimura, Juri Kiyokawa, Hiroto Yamaoka, Yasuhiro Murota, Yusuke Miwa, Shinji Yamamoto, Mariko Ishikawa, Shin Hirota
Publikováno v:
Japanese Journal of Neurosurgery. 30:598-603
Patients with Coronavirus disease 2019 (COVID-19) who receive extracorporeal membrane oxygenation (ECMO) tend to show extreme hypercoagulability and require intensive anticoagulant therapy. The prognosis is extremely poor in patients with intracrania
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a3c54cf1f3a67a3f4ee6ded5e5ca96f
https://doi.org/10.7887/jcns.30.598
https://doi.org/10.7887/jcns.30.598
Autor:
Shinji Yamamoto, Kei Ito, Yusuke Miwa, Yasuhiro Murota, Masataka Yoshimura, Toshihiko Hayashi, Azumi Kaneoka, Hiroto Yamaoka, Juri Kiyokawa, Mariko Ishikawa, Shin Hirota
Publikováno v:
Journal of Neuroendovascular Therapy. 15:489-497
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aed0b3fbf257f2e0823e69c332680b43
https://doi.org/10.5797/jnet.oa.2021-0013
https://doi.org/10.5797/jnet.oa.2021-0013